Northern New England Cystic Fibrosis Consortium

  • HOME

  • PATIENTS AND FAMILIES

    • Video Resources
    • Patient and Provider Links and Forms

  • RESEARCH

    • Clinical Trials
    • Publications
    • Posters 1998 to present

  • Members

  • Member Forum

  • More

    Use tab to navigate through the menu items.

    MISSION: TO CONTINUOUSLY IMPROVE THE QUALITY, SAFETY, EFFECTIVENESS AND COSTS OF CARE OF CF PATIENTS AND THEIR FAMILIES

    2011 to 2015

    K.E. Jarosz, M.D. Fletcher, B.S. Prato, J.B. Zuckerman, S. Morin.  Implementation of an Electronic Pulmonary Exacerbation Score Tool to Improve Treatment of Adult CF Patients.   MMC.  2011.

    Zuckerman JB1, Prato BS2, Zuaro D3, Saiman, L4 and the Infection Control Study Group.   Measuring Bacterial Shedding in Cystic Fibrosis Clinics.  NNECFC.  NACFC.  2012.

    AH Gifford, Dorman DB, Moulton LA, Parker HW, Stanton BA, OToole GA.  Hypoferremia reflects increased risk of antibiotic treatment in Cystic Fibrosis.  DHMC. NACFC.  2012.

    Gifford AH, Nymon AB, Ashare A.  Serum IGF-1 during CF pulmonary exacerbation:  Trends and biomarker correlations.  DHMC.  NACFC.  2012.

    Lisa M Bibler, Michelle Stinson, Alex Gifford.  Six-minute walk testing during hospitalization for CF pulmonary exacerbation.  DHMC.  NACFC.  2013.

    Gifford AH, Alexandru DM, Li Z, Dorman DB, Moulton LA, Price KE, Hampton TH, Sogin ML, Zuckerman JB, Parker HW, Stanton BA, OToole GA.  Iron supplementation does not worsen respiratory health in Cystic Fibrosis.  DHMC.  NACFC.  2013

    Gifford AH, Moulton LA, Dorman DB, Dolben EL, Hampton TH, Willger SD, Hogan DA.  Stability of Pseudomonas Aeruginosa gene transcription in Cystic Fibrosis sputum and correlation with CFQ-R respiratory symptom score.  DHMC.  NACFC.  2014.